Facts
as of Nov 20, 2026
Explore Ironwood Pharmaceuticals' commitment to GI health with innovative therapies, patient-focused research, and a vision to improve digestive disease treatment.
It is hiring: 2 open roles, 0 of them posted in the last 30 days.
- Legal name
- IRONWOOD PHARMACEUTICALS INC
- Headquarters
- Boston, United States
- Employees
- 76US Form 5500 (plan participants) · Dec 2025 · -66% in a year
- Listing
- NASDAQ: IRWD
- Open roles
- 2Alion job postings
- Register numbers
- EIN 043404176
As of Nov 20, 2026, Alion lists 2 open roles at Ironwood Pharmaceuticals. Ironwood Pharmaceuticals is headquartered in Boston, United States.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Ironwood Pharmaceuticals has $150M paid in by investors, lenders and donors.
Money innewest first
Loan or credit
Sep 2016 · Debt financing
$150MPaid
Revenue by yearas filed, with the net income
2025$296.2Mnet income $24M
2024$351.4Mnet income $880k
2023$442.7Mnet income −$1B
2022$410.6Mnet income $175.1M
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Ironwood Pharmaceuticals operates through 1 legal entity in 1 country.
Legal entities1 in 1 country
IRONWOOD PHARMACEUTICALS INC
operator · US EIN 043404176
US
Holders and shares as each register or filing states them.
2 open roles, 0 of them posted in the last 30 days.
2Open roles
76EmployeesUS Form 5500 (plan participants) · Dec 2025 · -66% in a year
$167kMedian H-1B wage, 20251 cases
Head countas filed and stated
Where the openings areshare of open roles
Finance33%▲
Science & Research33%▲
Biotech33%▼
Open roles over time−100%
Sep 14This week
Open roles a week: 1 then, 0 now
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Ironwood Pharmaceuticals has 39 clinical trials on record, 0 under way.
top 2%Web presenceof 133.2M domains by links, Common Crawl
Clinical trials
A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) Wi…
phase 2 · completed · 19 participants · as a collaborator · Functional Constipation
Apr 2023
A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndro…
phase 2 · stopped or withdrawn · 98 participants · Interstitial Cystitis; Bladder Pain Syndrome
Mar 2023
A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 t…
phase 3 · completed · 123 participants · as a collaborator · Functional Constipation (FC); Chronic Idiopathic Constipation (CIC)
Dec 2022
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Ironwood Pharmaceuticals: 87 research papers in five years.
Legal entity active
IRONWOOD PHARMACEUTICALS INC
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Milestones
Team shrank to 76 was 225 · US Form 5500 (plan participants)
2025
Sources: the outlets named on each headline, each story once
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
BostonBusiest site
Source: office addresses in postings and company registers
Tech stack
Technologies named in job postings at Ironwood Pharmaceuticals over the last 12 months, by layer, with the share of postings for each.
2Technologies in use
3Postings analysed
53/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site